Cargando…
Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer
Background. Intravenous ascorbic acid (IV AA) has been used extensively in cancer patients throughout the United States. Currently, there are limited data on the safety and clinical effects of IV AA. The purpose of this study was to expand the current literature using a retrospective analysis of adv...
Autores principales: | Bazzan, Anthony J., Zabrecky, George, Wintering, Nancy, Newberg, Andrew B., Monti, Daniel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142079/ https://www.ncbi.nlm.nih.gov/pubmed/29771164 http://dx.doi.org/10.1177/1534735418775809 |
Ejemplares similares
-
Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer
por: Monti, Daniel A., et al.
Publicado: (2012) -
N-acetyl Cysteine Administration Is Associated With Increased Cerebral Glucose Metabolism in Patients With Multiple Sclerosis: An Exploratory Study
por: Monti, Daniel A., et al.
Publicado: (2020) -
Resting-State Functional MRI Metrics in Patients With Chronic Mild Traumatic Brain Injury and Their Association With Clinical Cognitive Performance
por: Vedaei, Faezeh, et al.
Publicado: (2021) -
Alterations in cerebral glucose metabolism as measured by (18)F-fluorodeoxyglucose-PET in patients with persistent postconcussion syndrome
por: Teichner, Eric M., et al.
Publicado: (2021) -
Hybrid diffusion imaging reveals altered white matter tract integrity and associations with symptoms and cognitive dysfunction in chronic traumatic brain injury
por: Muller, Jennifer, et al.
Publicado: (2021)